Details for New Drug Application (NDA): 062564
✉ Email this page to a colleague
The generic ingredient in KANTREX is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 062564
Tradename: | KANTREX |
Applicant: | Apothecon |
Ingredient: | kanamycin sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062564
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 75MG BASE/2ML | ||||
Approval Date: | Sep 21, 1984 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/2ML | ||||
Approval Date: | Sep 21, 1984 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/3ML | ||||
Approval Date: | Sep 21, 1984 | TE: | RLD: | No |
Complete Access Available with Subscription